2020
DOI: 10.1002/cncr.33246
|View full text |Cite
|
Sign up to set email alerts
|

Sirolimus for patients with progressive epithelioid hemangioendothelioma

Abstract: Epithelioid hemangioendothelioma is an ultrarare soft tissue sarcoma with limited literature to guide treatment. The results from a robust retrospective cohort study support the use of sirolimus for patients who have multifocal epithelioid hemangioendothelioma without serosal effusion.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 20 publications
0
0
0
Order By: Relevance